Psychiatric Solutions, Inc. (MM) (NASDAQ:PSYS)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Psychiatric Solutions, Inc. (MM) Charts. Click Here for more Psychiatric Solutions, Inc. (MM) Charts.](/p.php?pid=staticchart&s=N%5EPSYS&p=8&t=15)
Psychiatric Solutions, Inc. (“PSI”)
(NASDAQ: PSYS) today announced financial results for the second quarter
ended June 30, 2008. Revenue was a record $451.0 million for the
quarter, up 28.4% from $351.2 million for the second quarter of 2007.
Income from continuing operations increased 40.5% to $0.52 per diluted
share for the second quarter of 2008 from adjusted income from
continuing operations of $0.37 per diluted share for the second quarter
last year, which excluded a loss on debt refinancing of $0.09 per
diluted share after tax. A reconciliation of all GAAP and non-GAAP
financial results in this release can be found on pages 6 and 7.
Same-facility revenue increased 7.8% for the second quarter of 2008,
driven by same-facility growth in net revenue per patient day of 5.1%
and growth in patient days of 2.7%. Same-facility EBITDA margin expanded
170 basis points to 21.8% compared with the second quarter of 2007, and
EBITDA margin for all facilities increased 130 basis points to 21.1%.
Consolidated adjusted EBITDA grew 34.7% to a record $81.5 million, or
18.1% of revenue, for the second quarter of 2008 from the same quarter
of 2007. Cash flow from continuing operations for the second quarter of
2008 was more than $41.5 million.
“PSI produced strong profitable growth for the
second quarter of 2008,” commented Joey
Jacobs, Chairman, President and Chief Executive Officer of PSI. “Demand
for high quality inpatient psychiatric care has continued to increase in
our fragmented, capacity-constrained industry, driving substantial
growth in our same-facility revenue. In addition, we have expanded PSI’s
capacity to meet increased demand through both accretive facility
acquisitions and the addition of more than 300 beds to existing and new
inpatient psychiatric facilities during the first half of 2008. As
expected, this volume growth and continuing initiatives to enhance
productivity in each facility have generated significant operating
leverage, expanding our profit margins.
“We expect to continue benefiting from strong
industry growth trends in 2008 and beyond. In this environment, we
remain highly focused on executing a proven business model that has
enabled us to build a long-term record of outstanding performance, while
also becoming the leading provider in the inpatient psychiatric care
industry. We are confident we have the opportunities, the resources and
the expertise to further strengthen our leadership position and enhance
stockholder value.”
Based on the Company’s results for the second
quarter and first half of 2008 and its outlook for the remainder of the
year, PSI today updated its guidance range for earnings from continuing
operations per diluted share for 2008 to $2.02 to $2.03, reflecting
growth of 36% compared to 2007. The Company’s
guidance does not include the impact from any future acquisitions.
PSI will hold a conference call to discuss its second quarter financial
results at 10:00 a.m. Eastern time on Thursday, July 31, 2008. A live
webcast of the conference call will be available at www.psysolutions.com
in the “Investors”
section of the site or at www.earnings.com.
The webcast will be available through the end of business on August 15,
2008.
This press release contains forward-looking statements within the
meaning of the “safe harbor”
provisions of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements include statements other than those
made solely with respect to historical fact and are based on the intent,
belief or current expectations of PSI and its management. PSI’s
business and operations are subject to a variety of risks and
uncertainties that might cause actual results to differ materially from
those projected by any forward-looking statements. Factors that could
cause such differences include, but are not limited to: (1) PSI’s
ability to successfully integrate recently acquired operations; (2)
potential competition which alters or impedes PSI's acquisition strategy
by decreasing PSI's ability to acquire additional inpatient facilities
on favorable terms; (3) the ability of PSI to improve the operations of
acquired inpatient facilities; (4) the ability to maintain favorable and
continuing relationships with physicians who use PSI's facilities; (5)
the ability to receive timely additional financing on terms acceptable
to PSI to fund PSI's acquisition strategy and capital expenditure needs;
(6) risks inherent to the health care industry, including the impact of
unforeseen changes in regulation, decreases in reimbursement rates from
federal and state health care programs or managed care companies and
exposure to claims and legal actions by patients and others; and (7) PSI’s
ability to comply with applicable licensure and accreditation
requirements. The forward-looking statements herein are qualified in
their entirety by the risk factors set forth in PSI's filings with the
Securities and Exchange Commission. PSI undertakes no obligation to
update any forward-looking statements, whether as a result of new
information, future events or otherwise. Readers should not place undue
reliance on forward-looking statements, which reflect management's views
only as of the date hereof.
PSI offers an extensive continuum of behavioral health programs to
critically ill children, adolescents and adults and is the largest
operator of owned or leased freestanding psychiatric inpatient
facilities with over 10,000 beds in 31 states, Puerto Rico and the U.S.
Virgin Islands. PSI also manages freestanding psychiatric inpatient
facilities for government agencies and psychiatric inpatient units
within medical/surgical hospitals owned by others.
PSYCHIATRIC SOLUTIONS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited, in thousands, except for per share amounts)
Three Months Ended
June 30,
Six Months Ended
June 30,
2008
2007
2008
2007
Revenue
$
450,965
$
351,223
$
877,744
$
670,791
Salaries, wages and employee benefits (including share-based
compensation of $4,517, $3,910, $10,077 and $7,583 for the
respective three and six month periods in 2008 and 2007)
246,231
193,364
483,118
371,797
Professional fees
46,385
35,000
89,724
65,643
Supplies
24,773
19,398
48,358
37,571
Rentals and leases
6,112
4,951
12,296
9,531
Other operating expenses
41,833
34,631
80,641
65,839
Provision for doubtful accounts
8,623
7,275
15,782
13,939
Depreciation and amortization
10,069
7,245
19,478
13,484
Interest expense
19,765
17,029
40,103
31,414
Loss on refinancing long-term debt
-
8,179
-
8,179
403,791
327,072
789,500
617,397
Income from continuing operations before income taxes
47,174
24,151
88,244
53,394
Provision for income taxes
17,844
8,961
33,533
20,198
Income from continuing operations
29,330
15,190
54,711
33,196
Loss from discontinued operations, net of income tax benefit of
$39, $64, $23 and $51 for the respective three and six month
periods in 2008 and 2007
(271
)
(583
)
(156
)
(464
)
Net income
$
29,059
$
14,607
$
54,555
$
32,732
Basic earnings per share:
Income from continuing operations
$
0.53
$
0.28
$
0.99
$
0.62
Loss from discontinued operations, net of taxes
-
(0.01
)
-
(0.01
)
Net income
$
0.53
$
0.27
$
0.99
$
0.61
Diluted earnings per share:
Income from continuing operations
$
0.52
$
0.27
$
0.98
$
0.60
Loss from discontinued operations, net of taxes
-
(0.01
)
(0.01
)
(0.01
)
Net income
$
0.52
$
0.26
$
0.97
$
0.59
Shares used in computing per share amounts:
Basic
55,279
54,104
55,211
53,955
Diluted
56,233
55,372
56,016
55,305
PSYCHIATRIC SOLUTIONS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited, in thousands)
June 30,
December 31,
2008
2007
ASSETS
Current assets:
Cash and cash equivalents
$
18,780
$
39,970
Accounts receivable, less allowance for doubtful accounts of
$44,678 and $35,587 for 2008 and 2007, respectively
263,552
231,993
Prepaids and other
78,467
67,382
Total current assets
360,799
339,345
Property and equipment, net of accumulated depreciation
760,065
693,677
Cost in excess of net assets acquired
1,198,598
1,073,583
Other assets
65,755
72,039
Total assets
$
2,385,217
$
2,178,644
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable
$
29,656
$
31,246
Salaries and benefits payable
86,688
82,458
Other accrued liabilities
60,640
61,794
Current portion of long-term debt
6,052
6,016
Total current liabilities
183,036
181,514
Long-term debt, less current portion
1,294,909
1,166,008
Deferred tax liability
56,418
49,131
Other liabilities
22,667
23,090
Total liabilities
1,557,030
1,419,743
Minority interest
4,606
4,159
Total stockholders' equity
823,581
754,742
Total liabilities and stockholders' equity
$
2,385,217
$
2,178,644
PSYCHIATRIC SOLUTIONS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited, in thousands)
Six Months Ended
June 30,
2008
2007
Operating activities:
Net income
$
54,555
$
32,732
Adjustments to reconcile net income to net cash provided by
continuing operating activities:
Depreciation and amortization
19,478
13,484
Amortization of loan costs and bond premium
1,105
1,038
Share-based compensation
10,077
7,583
Loss on refinancing long-term debt
-
8,179
Change in income tax assets and liabilities
432
(716
)
Loss from discontinued operations, net of taxes
156
464
Changes in operating assets and liabilities, net of effect of
acquisitions:
Accounts receivable
(30,529
)
(16,365
)
Prepaids and other current assets
379
(1,253
)
Accounts payable
(1,453
)
(5,437
)
Salaries and benefits payable
2,604
(4,693
)
Accrued liabilities and other liabilities
(3,133
)
6,311
Net cash provided by continuing operating activities
53,671
41,327
Net cash (used in) provided by discontinued operating activities
(1,468
)
824
Net cash provided by operating activities
52,203
42,151
Investing activities:
Cash paid for acquisitions, net of cash acquired
(157,953
)
(452,361
)
Capital purchases of property and equipment
(48,769
)
(28,929
)
Other assets
(481
)
(744
)
Net cash used in continuing investing activities
(207,203
)
(482,034
)
Net cash provided by discontinued investing activities
1,276
-
Net cash used in investing activities
(205,927
)
(482,034
)
Financing activities:
Net increase in revolving credit facility
130,000
9,000
Borrowings on long-term debt
-
481,875
Principal payments on long-term debt
(2,487
)
(39,918
)
Payment of loan and issuance costs
(30
)
(6,173
)
Refinancing long-term debt
-
(7,127
)
Excess tax benefits from share-based payment arrangements
815
3,566
Proceeds from exercises of common stock options
4,236
7,850
Net cash provided by financing activities
132,534
449,073
Net (decrease) increase in cash
(21,190
)
9,190
Cash and cash equivalents at beginning of the period
39,970
18,520
Cash and cash equivalents at end of the period
$
18,780
$
27,710
Effect of Acquisitions:
Assets acquired, net of cash acquired
$
164,558
$
513,674
Liabilities assumed
(6,605
)
(43,609
)
Common stock issued
-
(9,000
)
Long-term debt assumed
-
(8,704
)
Cash paid for acquisitions, net of cash acquired
$
157,953
$
452,361
PSYCHIATRIC SOLUTIONS, INC.
RECONCILIATION OF NET INCOME TO ADJUSTED INCOME FROM CONTINUING
OPERATIONS
(Unaudited, in thousands, except for per share amounts)
Three Months Ended
June 30,
Six Months Ended
June 30,
2008
2007
2008
2007
Net income
$ 29,059
$ 14,607
$ 54,555
$ 32,732
Plus reconciling items:
Discontinued operations, net of taxes
271
583
156
464
Provision for income taxes
17,844
8,961
33,533
20,198
Income from continuing operations before income taxes
47,174
24,151
88,244
53,394
Loss on refinancing long-term debt
-
8,179
-
8,179
Adjusted income from continuing operations before income taxes
47,174
32,330
88,244
61,573
Adjusted provision for income taxes
17,844
11,996
33,533
23,292
Adjusted income from continuing operations(a)
$ 29,330
$ 20,334
$ 54,711
$ 38,281
Income from continuing operations per diluted share
$ 0.52
$ 0.27
$ 0.98
$ 0.60
Adjusted income from continuing operations per diluted share
$ 0.52
$ 0.37
$ 0.98
$ 0.69
Diluted shares used in computing per share amounts
56,233
55,372
56,016
55,305
(a) PSI believes its
calculation of adjusted income from continuing operations provides
a better measure of the Company’s
ongoing performance and provides better comparability to prior
periods because it excludes items not related to the Company’s
core business operations. Adjusted income from continuing
operations should not be considered as a measure of financial
performance under accounting principles generally accepted in the
United States, and the items excluded from it are significant
components in understanding and assessing financial performance.
Because adjusted income from continuing operations is not a
measurement determined in accordance with accounting principles
generally accepted in the United States and is thus susceptible to
varying calculations, it may not be comparable as presented to
other similarly titled measures of other companies.
PSYCHIATRIC SOLUTIONS, INC.
RECONCILIATION OF INCOME FROM CONTINUING OPERATIONS TO EBITDA AND
ADJUSTED EBITDA
(Unaudited, in thousands)
Three Months Ended
June 30,
Six Months Ended
June 30,
2008
2007
2008
2007
Income from continuing operations
$
29,330
$
15,190
$
54,711
$
33,196
Provision for income taxes
17,844
8,961
33,533
20,198
Interest expense
19,765
17,029
40,103
31,414
Depreciation and amortization
10,069
7,245
19,478
13,484
EBITDA(a)
77,008
48,425
147,825
98,292
Other expenses:
Share-based compensation
4,517
3,910
10,077
7,583
Loss on refinancing long-term debt
-
8,179
-
8,179
Adjusted EBITDA(a)
$
81,525
$
60,514
$
157,902
$
114,054
(a)EBITDA and adjusted EBITDA
are non-GAAP financial measures. EBITDA is defined as income from
continuing operations before interest expense (net of interest
income), income taxes, depreciation and amortization. Adjusted
EBITDA is defined as income from continuing operations before
interest expense (net of interest income), income taxes,
depreciation, amortization, and other items included in the
caption above labeled “Other expenses”.
These other expenses may occur in future periods but the amounts
recognized can vary significantly from period to period and do not
directly relate to the ongoing operations of our health care
facilities. PSI’s management relies on
EBITDA and adjusted EBITDA as the primary measures to review and
assess operating performance of its facilities and their
management teams. PSI believes it is useful to investors to
provide disclosures of its operating results on the same basis as
that used by management. Management and investors also review
EBITDA and adjusted EBITDA to evaluate PSI’s
overall performance and to compare PSI’s
current operating results with corresponding periods and with
other companies in the health care industry. You should not
consider EBITDA and adjusted EBITDA in isolation or as a
substitute for net income, operating cash flows or other cash flow
statement data determined in accordance with accounting principles
generally accepted in the United States. Because EBITDA and
adjusted EBITDA are not measures of financial performance under
accounting principles generally accepted in the United States and
are susceptible to varying calculations, they may not be
comparable to similarly titled measures of other companies.
PSYCHIATRIC SOLUTIONS, INC.
OPERATING STATISTICS - OWNED FACILITIES
(Unaudited)
(Revenue in thousands)
Three Months Ended
June 30,
%
Change
2008
2007
Same-facility results:
Revenue
$
349,169
$
323,812
7.8%
Admissions
35,568
34,121
4.2%
Patient days
601,436
585,344
2.7%
Average length of stay(a)
16.9
17.2
-1.7%
Net revenue per patient day(b)
$
581
$
553
5.1%
EBITDA margin
21.8%
20.1%
170 bps
Total facility results:
Revenue
$
405,687
$
325,651
24.6%
Admissions
42,633
34,394
24.0%
Patient days
707,076
588,880
20.1%
Average length of stay(a)
16.6
17.1
-2.9%
Net revenue per patient day(b)
$
574
$
553
3.8%
EBITDA margin
21.1%
19.8%
130 bps
Six Months Ended
June 30,
%Change
2008
2007
Same-facility results:
Revenue
$
672,835
$
624,230
7.8%
Admissions
68,490
66,189
3.5%
Patient days
1,158,367
1,128,354
2.7%
Average length of stay(a)
16.9
17.0
-0.6%
Net revenue per patient day(b)
$
581
$
553
5.1%
EBITDA margin
21.9%
20.2%
170 bps
Total facility results:
Revenue
$
791,083
$
629,643
25.6%
Admissions
83,234
66,839
24.5%
Patient days
1,381,918
1,138,975
21.3%
Average length of stay(a)
16.6
17.0
-2.4%
Net revenue per patient day(b)
$
572
$
553
3.4%
EBITDA margin
21.0%
19.9%
110 bps
(a) Average length of stay is
defined as patient days divided by admissions.
(b) Net revenue per patient day
is defined as owned facility revenue divided by patient days.